MXPA02010088A - Derivados de ecteinascidina antitumorales. - Google Patents

Derivados de ecteinascidina antitumorales.

Info

Publication number
MXPA02010088A
MXPA02010088A MXPA02010088A MXPA02010088A MXPA02010088A MX PA02010088 A MXPA02010088 A MX PA02010088A MX PA02010088 A MXPA02010088 A MX PA02010088A MX PA02010088 A MXPA02010088 A MX PA02010088A MX PA02010088 A MXPA02010088 A MX PA02010088A
Authority
MX
Mexico
Prior art keywords
antitumoral
compounds
derivatives
ecteinascidin derivatives
antitumoral ecteinascidin
Prior art date
Application number
MXPA02010088A
Other languages
English (en)
Inventor
Carolina Fernandez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009043A external-priority patent/GB0009043D0/en
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Priority claimed from GB0022644A external-priority patent/GB0022644D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MXPA02010088A publication Critical patent/MXPA02010088A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se describen compuestos que tienen un sistema de cinco anillos de ecteinascidina fusionados con un puente 1,4 que tiene la estructura de la formula (Vla o Vlb) y los compuestos en donde el grupo -NH2 u -OH del puente 1,4 esta derivatizado. Dichos compuestos son utiles en el tratamiento de tumores. (ver formula).
MXPA02010088A 2000-04-12 2001-04-12 Derivados de ecteinascidina antitumorales. MXPA02010088A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0009043A GB0009043D0 (en) 2000-04-12 2000-04-12 New autitumoural derivatives of ET-743
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
GB0022644A GB0022644D0 (en) 2000-09-14 2000-09-14 Antitumoral derivatives of ET-743
PCT/GB2001/001667 WO2001077115A1 (en) 2000-04-12 2001-04-12 Antitumoral ecteinascidin derivatives

Publications (1)

Publication Number Publication Date
MXPA02010088A true MXPA02010088A (es) 2004-08-19

Family

ID=26244092

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010088A MXPA02010088A (es) 2000-04-12 2001-04-12 Derivados de ecteinascidina antitumorales.

Country Status (27)

Country Link
US (1) US7202361B2 (es)
EP (1) EP1280809B1 (es)
JP (1) JP5219323B2 (es)
KR (1) KR100886496B1 (es)
CN (1) CN1436191B (es)
AR (1) AR032879A1 (es)
AT (1) ATE299146T1 (es)
AU (1) AU784249C (es)
BG (1) BG65987B1 (es)
BR (1) BRPI0110024B8 (es)
CA (1) CA2406080C (es)
CZ (1) CZ304749B6 (es)
DE (1) DE60111845T2 (es)
DK (1) DK1280809T3 (es)
EA (1) EA006206B1 (es)
ES (1) ES2244598T3 (es)
HK (1) HK1049005B (es)
HU (1) HU230918B1 (es)
IL (1) IL152094A (es)
MX (1) MXPA02010088A (es)
NO (1) NO329125B1 (es)
NZ (1) NZ521550A (es)
PL (1) PL210703B1 (es)
PT (1) PT1280809E (es)
SI (1) SI1280809T1 (es)
SK (1) SK288017B6 (es)
WO (1) WO2001077115A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077698B1 (en) 1998-05-11 2005-03-02 Pharma Mar, S.A. Metabolites of ecteinascidin 743
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US7919493B2 (en) 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
HUP0401903A3 (en) * 2001-10-19 2008-07-28 Pharma Mar Improved use of et-743 in cancer thereapy
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
RS50692B (sr) 2003-11-13 2010-06-30 Pharma Mar S.A.U. Kombinacija et-743 sa prolekovima 5-fluorouracila za lečenje kancera
US20080242670A2 (en) * 2004-09-29 2008-10-02 Pharma Mar S.A., Sociedad Unipersonal Anti-Inflammatory Agents
DE602005001833T2 (de) 2004-10-29 2008-04-17 Pharma Mar S.A., Sociedad Unipersonal Zusammensetzungen enthaltend Ecteinascidin und einen Disaccharide
WO2006083417A2 (en) * 2004-12-20 2006-08-10 The Trustees Of Columbia University In The City Of New York Processes of making sesquiterpenoid tashironin, its analogs and their uses
WO2006079112A2 (en) * 2005-01-18 2006-07-27 The Trustees Of Columbia University In The City Of New York Enantioselective synthesis of merrilactone a and its analogs
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
WO2007087220A2 (en) * 2006-01-25 2007-08-02 The Trustees Of Columbia University In The City Of New York The total synthesis of ecteinascidin 743 and derivatives thereof
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
WO2011147828A1 (en) 2010-05-25 2011-12-01 Pharma Mar, S.A. Synthetic process for the manufacture of ecteinascidin compounds
RU2743643C2 (ru) 2010-11-12 2021-02-20 Фарма Мар, С.А. Комбинированная терапия противоопухолевым алкалоидом
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112679513B (zh) * 2019-10-18 2023-08-25 南通诺泰生物医药技术有限公司 一种制备曲贝替定的关键中间体的方法
CN114940682A (zh) * 2022-05-18 2022-08-26 博瑞制药(苏州)有限公司 芦比替定的晶型及其制备方法和用途
CN115677728A (zh) * 2022-11-02 2023-02-03 成都科岭源医药技术有限公司 一种海鞘素类化合物中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
WO1987007610A2 (en) 1986-06-09 1987-12-17 University Of Illinois Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
EP1077698B1 (en) * 1998-05-11 2005-03-02 Pharma Mar, S.A. Metabolites of ecteinascidin 743
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
AU783562B2 (en) * 2000-01-19 2005-11-10 Trustees Of Columbia University In The City Of New York, The Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
CZ20023352A3 (cs) 2003-05-14
US7202361B2 (en) 2007-04-10
IL152094A (en) 2011-10-31
HU230918B1 (hu) 2019-03-28
AU4672901A (en) 2001-10-23
CA2406080A1 (en) 2001-10-18
SI1280809T1 (sl) 2005-12-31
WO2001077115A1 (en) 2001-10-18
JP2003530402A (ja) 2003-10-14
DE60111845D1 (de) 2005-08-11
ATE299146T1 (de) 2005-07-15
SK14352002A3 (sk) 2003-04-01
BRPI0110024B1 (pt) 2019-07-16
CN1436191B (zh) 2011-09-14
DK1280809T3 (da) 2005-11-07
AU784249B2 (en) 2006-02-23
HUP0300534A2 (hu) 2003-07-28
NZ521550A (en) 2004-10-29
PL357574A1 (en) 2004-07-26
JP5219323B2 (ja) 2013-06-26
AR032879A1 (es) 2003-12-03
HUP0300534A3 (en) 2006-02-28
EP1280809B1 (en) 2005-07-06
US20030216397A1 (en) 2003-11-20
BR0110024A (pt) 2003-02-18
NO20024906L (no) 2002-11-27
BG107220A (en) 2003-05-30
CZ304749B6 (cs) 2014-09-24
DE60111845T2 (de) 2006-04-27
AU784249C (en) 2007-05-03
KR100886496B1 (ko) 2009-03-05
BRPI0110024B8 (pt) 2021-05-25
IL152094A0 (en) 2003-05-29
NO20024906D0 (no) 2002-10-11
HK1049005B (zh) 2006-01-27
EP1280809A1 (en) 2003-02-05
KR20030012864A (ko) 2003-02-12
EA200201083A1 (ru) 2003-04-24
PT1280809E (pt) 2005-11-30
CA2406080C (en) 2011-11-29
EA006206B1 (ru) 2005-10-27
ES2244598T3 (es) 2005-12-16
BG65987B1 (bg) 2010-08-31
PL210703B1 (pl) 2012-02-29
CN1436193A (zh) 2003-08-13
SK288017B6 (sk) 2012-11-05
NO329125B1 (no) 2010-08-30
HK1049005A1 (en) 2003-04-25

Similar Documents

Publication Publication Date Title
MXPA02010088A (es) Derivados de ecteinascidina antitumorales.
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
DE69925133D1 (de) Pyrrolobenzodiazepine
HK1046403A1 (en) Nematicidal trifluorobutenes.
MXPA03007140A (es) Derivados de carbolina.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
AU141695S (en) Respiratory mask
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
DE60216233D1 (en) Carbolinderivate
BG105028A (en) Bridged indenopyrrolocarbazoles
BG105112A (en) Agents with antidepressive effect
MXPA03002911A (es) Compuestos quimicos.
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
YU18801A (sh) Eletriptan hidrobromid monohidrat
BR0012751A (pt) Benzofuranos serotonérgicos
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
AP2001002369A0 (en) Pharmaceutical complex.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
MY128306A (en) Oct formulations
EP1436279A4 (en) CHEMICAL COMPOUNDS

Legal Events

Date Code Title Description
FG Grant or registration